GRCE vs DUO
Comparison between Acasti Pharma Inc (GRCE, Company) and Fangdd Network Group Ltd - Class A (DUO, Company).
GRCE is from the Healthcare sector, while DUO is from the Real Estate sector.
GRCE vs DUO - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
GRCE
$36M
DUO
$36M
Max Drawdown
Winner
GRCE
60.00%
DUO
98.75%
Sharpe Ratio
Winner
GRCE
0.02
DUO
-0.22
5Y Beta
Winner
GRCE
0.89
DUO
1.37
Industry
GRCE
Biotechnology
DUO
Real Estate Services
P/E Ratio
Winner
GRCE
-5.60
DUO
-1.76
Forward P/E
GRCE
2.17
DUO
N/A
Debt to Equity
GRCE
0.00%
DUO
0.00%
Free Cash Flow Yield
Winner
GRCE
-28.33%
DUO
-34.71%
P/S Ratio
GRCE
197.75
Winner
DUO
0.10
P/B Ratio
GRCE
0.56
Winner
DUO
0.42
GRCE vs DUO - Historical Returns
Returns include dividend reinvestment.
1M
Winner
GRCE
-5.58%
DUO
-33.14%
3M
GRCE
-45.81%
Winner
DUO
-27.07%
6M
Winner
GRCE
-33.53%
DUO
-54.74%
1Y
Winner
GRCE
-24.66%
DUO
-66.82%
Max(CAGR)
Winner
GRCE
-17.23%
DUO
-84.03%
GRCE vs DUO - Annual Returns (2024 - 2026)
Returns include dividend reinvestment.
| Year | GRCE | DUO |
|---|---|---|
| 2026 | -39.89% | -43.79% |
| 2025 | -13.50% | -85.72% |
| 2024 | +23.84% | -52.53% |
GRCE vs DUO Drawdown Comparison
The maximum drawdown for GRCE was -60.00%, occurring on Apr 7, 2025. Recovery took 323 trading sessions.
The maximum drawdown for DUO was -98.75%, occurring on Jun 8, 2026. This drawdown has not yet recovered.
The current GRCE drawdown is -57.12%. The current DUO drawdown is -98.74%.
| Rank | GRCE | DUO |
|---|---|---|
| #1 | -60.00% Dec 6, 2024 - Mar 25, 2026 | -98.75% Oct 2, 2024 - Jun 8, 2026 |
| #2 | -59.06% Apr 2, 2026 - Apr 28, 2026 | N/A |
| #3 | -18.06% Oct 23, 2024 - Dec 4, 2024 | N/A |
| #4 | -8.60% Mar 26, 2026 - Apr 1, 2026 | N/A |
| #5 | -5.57% Oct 10, 2024 - Oct 23, 2024 | N/A |
Correlation
Correlation between GRCE and DUO is 0.07 which considered as a very weak or no correlation - the stocks move independently of each other.
0.07
-101
Select Stocks to Compare
Popular: GRCE vs SPYDUO vs SPY
More Comparisons
Compare with similar stocks